Your browser doesn't support javascript.
loading
Impact of HOXB4 and PRDM16 Gene Expressions on Prognosis and Treatment Response in Acute Myeloid Leukemia Patients.
El-Meligui, Yomna M; Hassan, Naglaa M; Kassem, Amira B; Gouda, Nora A; Mohanad, Marwa; Hamouda, Manal A; Salahuddin, Ahmad.
Affiliation
  • El-Meligui YM; Clinical Pathology Department, National Cancer Institute, Cairo University, Cairo, Egypt.
  • Hassan NM; Clinical Pathology Department, National Cancer Institute, Cairo University, Cairo, Egypt.
  • Kassem AB; Clinical Pharmacy and Pharmacy Practice Department, Faculty of Pharmacy, Damanhour University, Damanhour, Egypt.
  • Gouda NA; Cancer Epidemiology and Biostatistics Department, National Cancer Institute, Cairo University, Cairo, Egypt.
  • Mohanad M; Biochemistry Department, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology, Giza, Egypt.
  • Hamouda MA; Clinical Pharmacy Department, Faculty of Pharmacy, Menoufia University, Shibin El Kom, Egypt.
  • Salahuddin A; Biochemistry Department, Faculty of Pharmacy, Damanhour University, Damanhour, Egypt.
Pharmgenomics Pers Med ; 15: 663-674, 2022.
Article in En | MEDLINE | ID: mdl-35782688
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Pharmgenomics Pers Med Year: 2022 Document type: Article Affiliation country: Egipto Country of publication: Nueva Zelanda
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Pharmgenomics Pers Med Year: 2022 Document type: Article Affiliation country: Egipto Country of publication: Nueva Zelanda